Clinical Trial Update: Phase III Study of KX-826 With Adult Male Patients With AGA [Phase 3]

View source ↗

Summary

Phase 3 study update for KX-826 in adult males with androgenetic alopecia (AGA) is in progress; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• KX-826

Snippet

Sponsor: Suzhou Kintor Pharmaceutical Inc, | Conditions: Androgenetic Alopecia | Phase 3 | Status: UNKNOWN